{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:21:34Z","timestamp":1783948894093,"version":"3.55.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bcmd.2026.103000","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:40:02Z","timestamp":1773909602000},"page":"103000","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Albumin fusion of the rVWF fragment rD'D3 reduces internalisation by clearance receptor Stabilin-2"],"prefix":"10.1016","volume":"119","author":[{"given":"Kim G.","family":"Lieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Pestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mhairi","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Han","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg T.","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Glauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Baz Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2026.103000_bb0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.blre.2013.06.002","article-title":"Hemophilia a in the third millennium","volume":"27","author":"Franchini","year":"2013","journal-title":"Blood Rev."},{"key":"10.1016\/j.bcmd.2026.103000_bb0010","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1016\/S0021-9258(19)69627-4","article-title":"The role of phospholipid and factor VIIIa in the activation of bovine factor X","volume":"256","author":"van Dieijen","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2026.103000_bb0015","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1182\/blood-2003-03-0941","article-title":"Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS study group","volume":"102","author":"Gringeri","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0020","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00228-009-0676-x","article-title":"Pharmacokinetics and dose requirements of factor VIII over the age range 3\u201374 years","volume":"65","author":"Bj\u00f6rkman","year":"2009","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.bcmd.2026.103000_bb0025","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0140-6736(92)90874-3","article-title":"Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs","volume":"339","author":"Ehrenforth","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2026.103000_bb0030","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1182\/blood-2006-11-056291","article-title":"Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia a: the CANAL cohort study","volume":"109","author":"Gouw","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0035","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1703068","article-title":"Emicizumab prophylaxis in hemophilia a with inhibitors","volume":"377","author":"Oldenburg","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2026.103000_bb0040","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa1803550","article-title":"Emicizumab prophylaxis in patients who have hemophilia a without inhibitors","volume":"379","author":"Mahlangu","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2026.103000_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1994.tb05127.x","article-title":"Biological effect of desmopressin in eight patients with type 2n (\u2018Normandy\u2019) von Willebrand disease","volume":"88","author":"Mazurier","year":"1994","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2026.103000_bb0050","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1538-7836.2007.02572.x","article-title":"Clearance mechanisms of von Willebrand factor and factor VIII","volume":"5","author":"Lenting","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2026.103000_bb0055","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2006-05-022756","article-title":"VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors","volume":"109","author":"Dasgupta","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0060","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood.2019001292","article-title":"BIVV001, a new class of factor VIII replacement for hemophilia a that is independent of von Willebrand factor in primates and mice","volume":"135","author":"Seth Chhabra","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0065","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1182\/bloodadvances.2019000999","article-title":"FVIII half-life extension by coadministration of a D\u2019D3 albumin fusion protein in mice, rabbits, rats, and monkeys","volume":"4","author":"Pestel","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2026.103000_bb0070","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1111\/jth.15480","article-title":"Increased potency of recombinant VWF D\u2019D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII","volume":"19","author":"Chia","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2026.103000_bb0075","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.bcmd.2026.103000_bb0080","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ejhg.2015.222","article-title":"Genome-wide association studies identify genetic loci for low von Willebrand factor levels","volume":"24","author":"van Loon","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bcmd.2026.103000_bb0085","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2350-12-102","article-title":"Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels","volume":"12","author":"Antoni","year":"2011","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.bcmd.2026.103000_bb0090","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1172\/JCI96400","article-title":"The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity","volume":"128","author":"Swystun","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcmd.2026.103000_bb0095","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/jth.14521","article-title":"The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen","volume":"17","author":"Swystun","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2026.103000_bb0100","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2012-10-457507","article-title":"The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels","volume":"121","author":"Rydz","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0105","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/jth.14404","article-title":"The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent manner","volume":"17","author":"Swystun","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.bcmd.2026.103000_bb0110","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3324\/haematol.2012.063297","article-title":"Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5","volume":"97","author":"Pegon","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2026.103000_bb0115","doi-asserted-by":"crossref","first-page":"G1191","DOI":"10.1152\/ajpgi.90717.2008","article-title":"Rat and human HARE\/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins","volume":"296","author":"Harris","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bcmd.2026.103000_bb0120","doi-asserted-by":"crossref","first-page":"17341","DOI":"10.1074\/jbc.M710360200","article-title":"The human hyaluronan receptor for endocytosis (HARE\/Stabilin-2) is a systemic clearance receptor for heparin","volume":"283","author":"Harris","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2026.103000_bb0125","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/glycob\/cwn045","article-title":"The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates a, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E","volume":"18","author":"Harris","year":"2008","journal-title":"Glycobiology"},{"key":"10.1016\/j.bcmd.2026.103000_bb0130","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.cdd.4402242","article-title":"Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor","volume":"15","author":"Park","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcmd.2026.103000_bb0135","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1128\/MCB.01993-07","article-title":"Epidermal growth factor-like domain repeat of Stabilin-2 recognizes phosphatidylserine during cell corpse clearance","volume":"28","author":"Park","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2026.103000_bb0140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.bbrc.2013.01.133","article-title":"Stabilin-2 acts as an engulfment receptor for the phosphatidylserine-dependent clearance of primary necrotic cells","volume":"432","author":"D\u2019Souza","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcmd.2026.103000_bb0145","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1074\/jbc.M607787200","article-title":"Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE)","volume":"282","author":"Harris","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2026.103000_bb0150","doi-asserted-by":"crossref","first-page":"33831","DOI":"10.1074\/jbc.274.48.33831","article-title":"Purification and subunit characterization of the rat liver endocytic Hyaluronan receptor","volume":"274","author":"Zhou","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2026.103000_bb0155","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia a","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0160","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/19420862.2015.1119352","article-title":"CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common \u03b2 chain of the IL-3, GM-CSF and IL-5 receptors","volume":"8","author":"Panousis","year":"2016","journal-title":"mAbs"},{"key":"10.1016\/j.bcmd.2026.103000_bb0165","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1074\/jbc.M117.817064","article-title":"Half-life-extended recombinant coagulation factor IX-albumin fusion protein is recycled via the FcRn-mediated pathway","volume":"293","author":"Chia","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2026.103000_bb0170","article-title":"Fcrn mediates fast recycling of endocytosed albumin and IgG from early macropinosomes in primary macrophages","volume":"133","author":"Toh","year":"2019","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcmd.2026.103000_bb0175","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1182\/blood.V116.21.4306.4306","article-title":"Siglecs as novel cellular partners for Von Willebrand factor","volume":"116","author":"Pegon","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0180","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.yexcr.2004.09.017","article-title":"Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin\/AP-2, independent of ligand binding","volume":"303","author":"Hansen","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcmd.2026.103000_bb0185","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.biocel.2010.03.024","article-title":"The conserved histidine in epidermal growth factor-like domains of stabilin-2 modulates pH-dependent recognition of phosphatidylserine in apoptotic cells","volume":"42","author":"Kim","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcmd.2026.103000_bb0190","first-page":"37","article-title":"Characterization of recombinant single chain FVIII, rVIII-SingleChain (CSL627)","volume":"18","author":"Schmidbauer","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.bcmd.2026.103000_bb0195","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1074\/jbc.M109.081828","article-title":"Cross-species binding analyses of mouse and human neonatal fc receptor show dramatic differences in immunoglobulin G and albumin Binding2","volume":"285","author":"Terje Andersen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2026.103000_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-32817-0","article-title":"Human and mouse albumin bind their respective neonatal fc receptors differently","volume":"8","author":"Nilsen","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcmd.2026.103000_bb0205","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1189\/jlb.0107052","article-title":"Stabilin-2 is involved in lymphocyte adhesion to the hepatic sinusoidal endothelium via the interaction with \u03b1M\u03b22 integrin","volume":"82","author":"Jung","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcmd.2026.103000_bb0210","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/biom9090454","article-title":"Discovery of the liver Hyaluronan receptor for endocytosis (HARE) and its progressive emergence as the multi-ligand scavenger receptor Stabilin-2","volume":"9","author":"Weigel","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcmd.2026.103000_bb0215","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1182\/blood-2011-08-373605","article-title":"Macrophage LRP1 contributes to the clearance of von Willebrand factor","volume":"119","author":"Rastegarlari","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0220","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.3324\/haematol.2018.210682","article-title":"Endocytosis by macrophages: interplay of macrophage scavenger receptor-1 and LDL receptor-related protein-1","volume":"105","author":"Eelke","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.bcmd.2026.103000_bb0225","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/eji.1830250224","article-title":"Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs","volume":"25","author":"Hughes","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bcmd.2026.103000_bb0230","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nm1760","article-title":"The Ashwell receptor mitigates the lethal coagulopathy of sepsis","volume":"14","author":"Grewal","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcmd.2026.103000_bb0235","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood-2017-06-787853","article-title":"A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance","volume":"131","author":"Ward","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0240","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1182\/blood-2018-99-114775","article-title":"Defining the molecular mechanisms through which the macrophage galactose lectin (MGL) receptor regulates Von Willebrand factor clearance","volume":"132","author":"Ward","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0245","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2014.03.028","article-title":"Non-clinical pharmacokinetics and pharmacodynamics of rVIII-SingleChain, a novel recombinant single-chain factor VIII","volume":"134","author":"Zollner","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bcmd.2026.103000_bb0250","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1038\/emboj.2011.286","article-title":"Endosome maturation","volume":"30","author":"Huotari","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.bcmd.2026.103000_bb0255","doi-asserted-by":"crossref","first-page":"e0124930","DOI":"10.1371\/journal.pone.0124930","article-title":"FcRn rescues recombinant factor VIII fc fusion protein from a VWF independent FVIII clearance pathway in mouse hepatocytes","volume":"10","author":"van der Flier","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcmd.2026.103000_bb0260","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1182\/blood.2025029401","article-title":"A bispecific nanobody for the treatment of von Willebrand disease type 1","volume":"146","author":"Peyron","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2026.103000_bb0265","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1084\/jem.20021829","article-title":"The major histocompatibility complex-related fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan","volume":"197","author":"Chaudhury","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcmd.2026.103000_bb0270","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1159\/000487168","article-title":"Fusion to human serum albumin extends the circulatory half-life and duration of antithrombotic action of the Kunitz protease inhibitor domain of protease nexin 2","volume":"45","author":"Sheffield","year":"2018","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:08:00Z","timestamp":1780337280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979626000239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":54,"alternative-id":["S1079979626000239"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.103000","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Albumin fusion of the rVWF fragment rD'D3 reduces internalisation by clearance receptor Stabilin-2","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.103000","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103000"}}